Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study
Authors not listed
Johns Hopkins University · 2021
Abstract
The ACHIEVE Hearing Intervention Follow-Up study is a randomized trial of a telehealth versus conventional clinic-based hearing healthcare (HHC) delivery model among older adults who are existing hearing aid users to determine if a telehealth HHC model improves hearing aid use and other communication outcomes compared to clinic-based HHC.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-07 MST
Cite this
APA
Anonymous. (2021). Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study. <em>Johns Hopkins University</em>. https://clinicaltrials.gov/study/NCT05070429
Vancouver
Anonymous. Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study. Johns Hopkins University. 2021.
BibTeX
@misc{anon2021Random,
title = {Randomized Trial of Telehealth vs. Conventional Hearing Care Delivery in the ACHIEVE Study},
author = {Anonymous},
journal = {Johns Hopkins University},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Indiana University 2010
Open access · US-GOV
Alzheimer's Disease Multiple Intervention Trial
Universidad Rey Juan Carlos 2023
Open access · US-GOV
Effects of Nintendo Switch on Rehabilitation Programs for Elderly People With Cognitive Impairment: A Randomized Clinical Trial
Universidad de Burgos 2026
Open access · US-GOV
Effects of Creatine Monohydrate and β-Hydroxy-β-Methylbutyrate Supplementation Combined With Multicomponent Exercise on Physical Performance, Cognition and Quality of Life in Institutionalized Older Adults: A Randomized Double-Blind Parallel-Group Trial
Johns Hopkins University 2015
Open access · US-GOV
Aging, Cognition, and Hearing Evaluation in Elders Pilot Study
Eidos Therapeutics, a BridgeBio company 2019
Open access · US-GOV
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects With Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTRibute-CM Trial)
Purdue University 2012
Open access · US-GOV